OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
The Medicare Rx drug benefit could slash independent pharmacies' gross margins by 8%, sending them over the edge of unprofitability, according to industry analyst Arthur Flynn.
Related Content:
News